missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Viral CCI Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 696-CC-025
285.09 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Viral CCI Fc Chimera Protein is derived from Sf 21 (baculovirus). The Recombinant Viral CCI Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| CCI Fc Chimera | |
| Spodoptera frugiperda,Sf 21 (baculovirus)-derived viral CCI protein, (N-terminus) Viral CCI (Met17-Val258) & (Pro18-Val258) Accession # P19063 IEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |
| 57 kDa (monomer) | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |